3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Gliosarcoma
7
Glioblastoma
6
Sarcoma
5
Brain Neoplasms
5
Astrocytoma
5
Oligodendroglioma
4
Neuroblastoma
3
Glioma
3
Wilms Tumor
2
Recurrence
2
Neoplasm Metastasis
2
Medulloblastoma
2
Lymphoma, Large B-Cell, Diffuse
2
Dendritic Cell Sarcoma, Interdigitating
2
Burkitt Lymphoma
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Optic Nerve Glioma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Meningioma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leiomyosarcoma
1
Hepatoblastoma
1
Familial ependymoma
1
Interventions
Cyclophosphamide
25
Temozolomide
22
Vincristine
18
Irinotecan
18
Doxorubicin
13
Topotecan
10
Melphalan
10
Etoposide
10
Ifosfamide
8
Busulfan
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
Granulocyte Colony-Stimulating Factor
7
Filgrastim
6
regorafenib
5
fludarabine
5
X-Rays
5
Specimen Handling
5
Sirolimus
5
Radiotherapy
5
Gemcitabine
5
Drug Therapy
5
pegfilgrastim
4
palbociclib
4
liposomal doxorubicin
4
irinotecan sucrosofate
4
ganitumab
4
fludarabine phosphate
4
Trabectedin
4
Phantoms, Imaging
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Vorinostat
×
Sarcoma
×
Clear all
NCT04308330
2026-04-15
NYMC195
New York Medical College
Phase 1
Recruiting
30 enrolled